StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.96+0.07 (+3.70%)

Close on Nov 17, 2026Market cap $18.90MP/E –Yield –

Edesa Biotech price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Edesa Biotech's price to book ratio was 2.4× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.7× to 40.1×, with a median of 3.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.4×+1.6
2025Dec 31, 20250.8×−1.9
2024Dec 31, 20242.8×+0.8
2023Dec 29, 20232.0×−1.8
2022Dec 30, 20223.8×−36.3
2021Dec 31, 202140.1×−3.0
2020Dec 31, 202043.1×+2.2
2019Dec 31, 201941.0×−16.4
2018Dec 31, 201857.4×+9.0
2017Dec 29, 201748.4×−21.8
2016Dec 30, 201670.2×−206.9
2015Dec 31, 2015277.1×−218.1
2014Dec 31, 2014495.2×+67.2
2012Nov 30, 2012428.0×–

More Edesa Biotech figures

See a number that looks wrong?